Dr Samantha Thomas, at the event on 8 November entitled “Targeted Delivery of Therapeutic Payloads Using Stem Cell derived Exosome”, presented in vivo data exemplifying the cellular and tissue targeting capabilities and highlighting the significant advantages of ReNeuron’s CustomEX™ drug delivery platform.

The presentation can be viewed by clicking here.